Graves' disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Rasul, Samad ^a   Delapenha, Robert ^a   Farhat, Faria ^a   Gajjala, Jhansi ^a   Zahra, Syeda Mehreen ^a  

^a HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869993492     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/743597     Document Type: Article

References (13)

1. Palella F. J., Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. The New England Journal of Medicine 1998 338 13 853 860 2-s2.0-2642709177 10.1056/NEJM199803263381301 (Pubitemid 28135961)
2. Beatty G. W., Immune Reconstitution Inflammatory Syndrome. Emergency Medicine Clinics of North America 2010 28 2 393 407 2-s2.0-77952515470 10.1016/j.emc.2010.01.004
3. Jimenez C., Moran S. A., Sereti I., Wynne S., Yen P. M., Falloon J., Davey R. T., Sarlis N. J., Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. Thyroid 2004 14 12 1097 1102 2-s2.0-11344260900 10.1089/thy.2004.14.1097 (Pubitemid 40076137)
4. Chen F., Day S. L., Metcalfe R. A., Sethi G., Kapembwa M. S., Brook M. G., Churchill D., De Ruiter A., Robinson S., Lacey C. J., Weetman A. P., Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine 2005 84 2 98 106 2-s2.0-20144375986 10.1097/01.md. 0000159082.45703.90 (Pubitemid 40418638)
5. Vos F., Pieters G., Keuter M., van der Ven A., Graves' disease during immune reconstitution in HIV-infected patients treated with HAART. Scandinavian Journal of Infectious Diseases 2006 38 2 124 126 2-s2.0-32144454005 10.1080/00365540500348960 (Pubitemid 43203238)
6. French M. A., Lewin S. R., Dykstra C., Krueger R., Price P., Leedman P. J., Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Research and Human Retroviruses 2004 20 2 157 162 2-s2.0-1442274717 10.1089/088922204773004879 (Pubitemid 38280926)
7. Jubault V., Penfornis A., Schillo F., Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1 infected patients. The Journal of Clinical Endocrinology & Metabolism 2000 85 4254 4257 (Pubitemid 32055382)
8. Weetman A., Immune reconstitution syndrome and the thyroid. Best Practice and Research & Clinical Endocrinology & Metabolism 2009 23 6 693 702 2-s2.0-71749087718 10.1016/j.beem.2009.07.003
9. Knysz B., Bolanowski M., Klimczak M., Gladysz A., Zwolinska K., Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunology 2006 19 1 102 107 2-s2.0-33645467705 10.1089/vim.2006.19.102
10. Gilquin J., Viard J. P., Jubault V., Sert C., Kazatchkine M. D., Delayed occurrence of Graves' disease after immune restoration with HAART. The Lancet 1998 352 9144 1907 1908 2-s2.0-0032512301 (Pubitemid 28561258)
11. Crum N., Ganesan A., Johns S., Wallace M. R., Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS 2006 20 3 466 469 2-s2.0-33645030503 10.1097/01.aids.0000196173.42680.5f
12. Hoffmann C. J., Brown T. T., Thyroid function abnormalities in HIV-infected patients. Clinical Infectious Diseases 2007 45 4 488 494 2-s2.0-34547640861 10.1086/519978 (Pubitemid 47204469)
13. Nelson M., Powles T., Zeitlin A., Sen P., Scourfield A., Bower M., Gazzard B., Stebbing J., Thyroid dysfunction and relationship to antiretroviral therapy in hiv-positive individuals in the HAART era. Journal of Acquired Immune Deficiency Syndromes 2009 50 1 113 114 2-s2.0-64249167165 10.1097/QAI. 0b013e31818ce835